IBEC staff gather for IBEC Day to mark the institute’s 20th anniversary
Over 200 people took part in IBEC Day 2026, an event designed to encourage sharing, connection and celebration in honour of the institute’s 20th anniversary.
Samuel Sanchez
Group leader
Samuel Sánchez receives the Rei Jaume I Award in the New Technologies category
The prize recognises the research work of Sánchez, ICREA Research Professor at IBEC. These awards, presented by the Valencian Foundation Rei Jaume I Awards, aim to bring science and business closer together in order to promote research, scientific development and entrepreneurship in Spain.
IBEC showcases cutting-edge biomedical innovation at the Health Revolution Congress 2026
The Institute for Bioengineering of Catalonia brought together researchers, investors and industry leaders with its event “IBEC Health Revolution Day: Engineering the Future of Medicine”, as part of the Health Revolution Congress. Through expert panels, technology pitches and scientific talks, the event showcased cutting-edge biomedical technologies and discussed how to translate scientific discoveries into real-world healthcare solutions.
IBEC makes its mark at TERMISEU 2026 with a strong scientific presence and a key role in the conference’s leadership
From 21 to 24 April 2026, IBEC had a significant presence at TERMISEU 2026, the leading European conference on tissue engineering and regenerative medicine. Held at the Palma Conference Centre in Mallorca, the event brought together more than 1,600 researchers.
A new generation of therapeutic nanorobots set to transform the medicine of the future
Research carried out at IBEC by Samuel Sánchez and his team has led to the development of a new generation of therapeutic nanorobots. These nanorobots can move through the body, reach tumours and deliver drugs with great precision. These nanorobots have already reduced bladder tumours by up to 90% in preclinical models and are being investigated for use in treating other diseases. They were presented to the public at MWC26 through an immersive experience demonstrating how this technology could transform future treatments.
IBEC welcomes a new international cohort of doctoral students in collaboration with hospitals and centres of excellence
The Institute for Bioengineering of Catalonia (IBEC) is pleased to welcome new international students to its PhD programme. This initiative offers excellent training and research opportunities in bioengineering, as well as strong collaboration with leading hospitals and institutions.
IBEC showcases its leadership in biomedical innovation at MWC26 with three disruptive projects
Last week, Barcelona played host to MWC26, the world’s premier technology and connectivity event. The Institute for Bioengineering of Catalonia was in attendance, showcasing some of its spin-offs and state-of-the-art biomedical technologies, including: Nanobots Therapeutics, Lumiris Spectral Solutions, and Drug4Sight.
CÁMARA REAL | TELEMADRID: El Rey comprueba los avances de la tecnología en la salud
El Rey visita el Mobile Wold Congress donde comprueba los avances de la tecnología en la salud. Allí se reencuentra con Samuel Sánchez, que presenta sus nanorrobots.
LA VANGUARDIA: Nanobots para redefinir la medicina del mañana
En el stand de Mobile World Capital Barcelona, una experiencia desarrollada conjuntamente con Nanobots Therapeutics muestra el potencial de los nanobots terapéuticos como nueva herramienta para el tratamiento de enfermedades como el cáncer. La empresa es una derivada del Institut de Bioenginyeria de Catalunya y de ICREA, y representa un paso adelante en la transferencia de investigación hacia la práctica clínica.
Three IBEC researchers receive grants from the Spanish Association Against Cancer
Three research projects led by IBEC researchers Xavier Rovira-Clavé, David Esporrín Ubieto and Aránzazu Villasante have been selected by the Spanish Association Against Cancer for its 2025 Grant Programme. The grant presentation ceremony, held in Barcelona today, recognised the momentum behind these initiatives, which range from advanced cell therapy platforms to smart nanomotors and innovative paediatric tumour treatment strategies.